Global private equity and venture capital news and research

Posts Tagged ‘R&D’

11 November 2015

RiverVest closes $40.5m Series C round in US Amplyx Pharmaceuticals

laboratory-829371_1920 Life sciences-focused RiverVest Venture Partners has led a $40.5m Series C round in Amplyx Pharmaceuticals, a San-Diego based developer of treatments of life-threatening fungal infections.

29 September 2015

Rock Springs leads $75m Series B round in Corvus Pharmaceuticals

research-853474_1280 Rock Springs Capital Management was lead investor in a $75m Series B financing round for US cancer treatment researcher Corvus Pharmaceuticals.

10 April 2014

Waterland Private Equity exits Euronext-listed healthcare company Arseus

Netherlands-based Waterland Private Equity has exited its stake in Euronext-listed scientific R&D company Arseus.

17 February 2014

BGF invests £3.4m in Jumpstart to support R&D tax relief claims

UK-based Business Growth Fund has made a £3.4m growth capital investment into Edinburgh-based Jumpstart, which supports businesses make HMRC R&D tax relief claims.

10 June 2013

UK’s Regional Growth Fund backs new technology R&D programme

Romax Technology and the University of Sheffield are launching a research and development centre with the support of the UK’s Regional Growth Fund.

11 March 2013

UK government provides £3.7m for healthcare R&D investment

The UK government is to dish out £3.7m to fund businesses developing photonics technologies for the healthcare sector.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015